好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Psychogenic Movement Disorders

Wednesday 03/20/13
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Aikaterini Kompoliti, MD, FAAN
Participants should be able to describe the clinical phenomenology, epidemiology, and clinical impact of psychogenic movement disorders; recognize other conditions that share features in common with psychogenic movement disorders and could be mistakenly identified as psychogenic; and develop a practical approach to the examination, diagnosis, and treatment of psychogenic movement disorders.
No CME available
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
06:30 AM - 07:10 AM Phenomenology and Clinical Impact
Aikaterini Kompoliti, MD, FAAN
06:30 AM - 08:30 AM Break
07:10 AM - 07:50 AM The Psychiatrist's Perspective
Michael Schrift, DO
07:50 AM - 08:30 AM Treatment Options and Prognosis
Aikaterini Kompoliti, MD, FAAN, Michael Schrift, DO
Faculty Disclosures
Aikaterini Kompoliti, MD, FAAN Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Michael Schrift, DO No disclosure on file